EDITORIAL
Published on 23 Nov 2023
Editorial: Molecular genetic testing and emerging targeted therapies for non-small cell lung cancer
doi 10.3389/fonc.2023.1308525
- 897 views
- 4 citations
- Frontiers in Oncology
- Thoracic Oncology
- Research Topics
- Molecular Genetic Testing and Emerging Targeted Therapies for Non-Small Cell Lung Cancer
Molecular Genetic Testing and Emerging Targeted Therapies for Non-Small Cell Lung Cancer
6,032
Total downloads
20k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 22 May 2023
EGFR and ERBB2 exon 20 insertion/duplication in advanced non–small cell lung cancer: genomic profiling and clinicopathologic features
doi 10.3389/fonc.2023.1163485
- 4,418 views
- 2 citations
CASE REPORT
Published on 14 Mar 2023
Response to selpercatinib in a patient with RET fusion-positive pulmonary large-cell neuroendocrine carcinoma: A case report
doi 10.3389/fonc.2023.1134151
- 1,982 views
- 7 citations
ORIGINAL RESEARCH
Published on 14 Dec 2022
Next-generation sequencing of homologous recombination genes could predict efficacy of platinum-based chemotherapy in non-small cell lung cancer
doi 10.3389/fonc.2022.1035808
- 1,699 views
- 5 citations
REVIEW
Published on 27 Oct 2022
MET-targeted therapies for the treatment of non-small-cell lung cancer: A systematic review and meta-analysis
doi 10.3389/fonc.2022.1013299
- 5,029 views
- 10 citations
ORIGINAL RESEARCH
Published on 21 Oct 2022
Integrative genomic analysis of drug resistance in MET exon 14 skipping lung cancer using patient-derived xenograft models
doi 10.3389/fonc.2022.1024818
- 2,407 views
- 7 citations
CASE REPORT
Published on 06 Oct 2022
A non-functional 5′ ALK fusion validated at the RNA level as a classical EML4-ALK that responds well to the novel ALK inhibitor ensartinib: A case report
doi 10.3389/fmed.2022.979032
- 1,628 views
- 1 citation
